Official Show Preview

Hedinger, based in Stuttgart, Germany, is a distributor of Egypt’s Global Napi Pharmaceuticals boasts up-to-date
pharmaceutical excipients offering GMP-standard handling, full technology and production facilities. It is guided by a long-term
traceability and pharmaceutical lot speciﬁ c COAs. It also offers business strategy which includes sustainable development.
special grades for parenteral applications.
Fuji Chemical Industry of Japan offers specialised platforms
Another German ﬁ rm, Harke Pharma, is a distributor of for solid dispersion technology to enhance the solubility and
pharmaceutical excipients and services with more than 30 years’ bioavailability of poorly water soluble drugs. It offers organic
experience in the European market. Its technical consultants are solvent feed closed cycle spray dry system or speciality granular
experts in the ﬁ eld of innovative excipients for solid and semi-solid excipients that can be used as carriers for hot melt, solvent
dosage forms. adsorption or SMEDDS.
JRS Pharma is an excipients ﬁ rm focused on innovative products,
Synthon is a Dutch company that develops, manufactures and
patented technologies and technical expertise for solid dosage
out-licenses speciality generics. Synthon offers a broad portfolio
forms in the pharmaceutical and nutritional industries worldwide.
of generic products with numerous early-entry opportunities.
Gattefossé of France develops innovative technology products
The ﬁ rm’s products are made available worldwide through local
for bioavailability improvement, sustained-release, lubrication,
marketing partners. Furthermore, Synthon provides international
solubilisation, and is represented in more than 40 countries
regulatory and IP support.
worldwide.
The French ﬁ rm Roquette Pharma aims for a consistent supply of
Italy’s Lisapharma has developed a new sucralfate form and
innovative technologies and the highest quality of ingredients. The
patented a pharmaceutical form of sucralfate humid-gel, called
ﬁ rm’s latest technology platform comprises a new functionalised
Skincol, intended for the management of wounds, burns,
mannitol compound ideal for orodispersible tablet formulations:
vascular ulcers, bedsores and any dermal lesion requiring
Pearlitol Flash.
hospitalisation.
SPI Pharma is a global supplier to the pharmaceutical,
Panreac Synthesis is the business unit of Spain’s Panreac
nutraceutical and animal health markets. Its applications include
Quimica, a leader in the manufacture of reagents, solvents
solid dose formulations, dry powder suspensions, taste masking
and ﬁ ne chemicals. It offers custom synthesis projects and a
and controlled-release systems, viscous suspensions, chewing
wide range of pharmacopeia-grade products according to
gum systems, effervescent systems and custom granulations. SPI
10 the requirements of the main pharmacopoeias used in the
Pharma recently announced the launch of Pharmaburst 500.
pharmaceutical industry.
Nitika Chemicals of India will be in Madrid to talk visitors
Portugal’s Grupo Azevedos offers a wide range of services
through its ISO 9001 & 14001 & WHO-GMP certiﬁ ed facilities
including R&D of new formulations, contract manufacturing,
where it produces regular and DC excipients. The company also
stability studies, logistics, and distribution as well as national and
has US DMF no.18912/EDMF no.1252 from the US FDA, DMF for
international marketing.
some of its products.
MSN Group is an Indian manufacturer of APIs and key
Domo (Friesland Foods) is a leading Dutch manufacturer
pharmaceutical intermediates. Its facilities are ISO 9001-2000
of pharmaceutical lactose. Its product range includes alpha
certiﬁ ed and internationally approved. Its portfolio consists of
monohydrate, spray-dried and anhydrous lactose.
more than 60 products, with more than 20 new products under
Eurand is a global speciality company that develops,
development.
manufactures and commercialises enhanced pharmaceutical
India’s Pharmaceutical Coatings manufactures ﬁ lm coating
products based on its proprietary drug formulation technologies.
materials and direct compression excipients. Specifar, based in
Eurand has a track record of developing products using its drug
Athens, Greece, offers the development of generic formulations,
formulation technology platforms.
licensing activities and regulatory services.
Syral of France is a producer of starch-based pharmaceutical
Aptys Pharmaceuticals of France will be seeking new clients
excipients: polyols, starches, dextrose, maltodextrins and glucose
for its innovative drug delivery technology, its know-how in
syrups. These excipients, produced from natural raw materials,
solid, semi-solid and liquid dosage forms, and its proprietary provide bulking, dissolution and compressibility properties to liquid
technologies for the development of drug products. and solid applications including clinical nutrition.
Sheffi eld Pharma, part of the Kerry Group, has expertise in the Pharmathen is a European generics developer, manufacturing
manufacture of cGMP-compliant pharmaceutical-grade lactose, APIs and ﬁ nished formulations in three research facilities and
ﬂ avourings and coatings for drug delivery systems. Its product three ﬁ nished formulation facilities. The company recently made
offering includes Foremost Fast Flo and Shefﬁ eld Anhydrous Direct its entrance into the ﬁ eld of innovative products. In addition, its
Tabletting. newest manufacturing plant has begun operations.
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44